Active Ingredient: Ciprofloxacin
Immunizations The following are the recommended vaccinations for Bolivia.
Hepatitis A vaccine is recommended for all travelers over one year of age. It should be given at least two weeks preferably four weeks or more before departure. A booster should be given 6-12 months later to confer long-term immunity.
Both are well-tolerated. Older adults, immunocompromised persons, and those with chronic liver disease or other chronic medical conditions who have less than two weeks before departure should receive a single intramuscular dose of immune globulin 0.
Travelers who are less than one year of age or allergic to a vaccine component should receive a single intramuscular dose of immune globulin see hepatitis A for dosage in the place of vaccine.
Typhoid vaccine is recommended for all travelers, with the exception of short-term visitors who restrict their meals to major restaurants and hotels, such as business travelers.
It is generally given in an oral form Vivotif Berna consisting of four capsules taken on alternate days until completed. The capsules should be kept refrigerated and taken with cool liquid.
PDF, given as a single dose. The oral vaccine is approved for travelers at least six years old, whereas the injectable vaccine is approved for those over age two.
There are no data concerning the safety of typhoid vaccine during pregnancy. The injectable vaccine Typhim Vi is probably preferable to the oral vaccine in pregnant and immunocompromised travelers.
Yellow fever vaccine is recommended for all travelers greater than nine months of age traveling to the following areas east of the Andes Mountains less than 2300 m in elevation: the entire departments of Beni, Pando, Santa Cruz, and designated areas see map of Chuquisaca, Cochabamba, La Paz, and Tarija.
Not recommended for travelers whose itineraries are limited to areas greater than 2300 m in elevation and all areas not listed above, including the cities of La Paz and Sucre.
Campylobacter fetus bloodstream infection: risk factors and clinical features. Kubota.
Ishiguro. Tomino, and H. Campylobacter fetus subspecies fetus peritonitis in continuous ambulatory peritoneal dialysis. Nephron -488.